Lindsay Rocco | Elixir Health Public Relations |
John Johnson | Executive Chairman |
Fred Cohen | Chief Medical Officer |
Scott Wilhoit | Chief Commercial Officer |
Rob Lutz | CFO |
Chris Howerton | Jefferies |
Hartaj Singh | Oppenheimer |
Esther Hong | Janney Montgomery Scott |
Ladies and gentlemen, thank you for standing by and welcome to Strongbridge Biopharma Plc Corporate Update and Fourth Quarter 2019 Earnings Conference Call. At this time all participants are in a listen only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions]
It is now my pleasure to introduce Lindsay Rocco of Elixir Health Public Relations.